| Patent | Date |
|---|
Cannabinoid Receptor Modulators
App 20220241274 - Thatte; Jayant ; et al. | 2022-08-04 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders
App 20220002244 - Blackburn; Anthony C. ; et al. | 2022-01-06 |
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators
App 20210380560 - Blackburn; Anthony C. ; et al. | 2021-12-09 |
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(compound1) for use in S1P.sub.1 receptor-associated disorders
Grant 11,091,435 - Blackburn , et al. August 17, 2 | 2021-08-17 |
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
Grant 10,981,895 - Blackburn , et al. April 20, 2 | 2021-04-20 |
Cannabinoid Receptor Modulators
App 20210060040 - Thatte; Jayant ; et al. | 2021-03-04 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders
App 20200361869 - Blackburn; Anthony C. ; et al. | 2020-11-19 |
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compound 1) for use in SIPI receptor-associated disorders
Grant 10,676,435 - Blackburn , et al. | 2020-06-09 |
Cannabinoid receptor modulators
Grant 10,632,134 - Thatte , et al. | 2020-04-28 |
Cannabinoid Receptor Modulators
App 20200069681 - Thatte; Jayant ; et al. | 2020-03-05 |
Modified-release dosage forms of 5-HT.sub.2C agonists useful for weight management
Grant 10,463,676 - Shao , et al. No | 2019-11-05 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-
App 20190330153 - Blackburn; Anthony C. ; et al. | 2019-10-31 |
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators
App 20190308952 - Blackburn; Anthony C. ; et al. | 2019-10-10 |
Modified-Release Dosage Forms of 5-Ht2c Agonists Useful for Weight Management
App 20190275055 - Shao; Zezhi Jesse ; et al. | 2019-09-12 |
Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydroc- yclo-penta [b]indol-3-yl)acetic acid(Compund1) for use in SIPI receptor-associated disorders
Grant 10,301,262 - Blackburn , et al. | 2019-05-28 |
Modified-release dosage forms of 5-HT.sub.2C agonists useful for weight management
Grant 10,226,471 - Shao , et al. | 2019-03-12 |
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
Grant 10,183,930 - Blackburn , et al. Ja | 2019-01-22 |
Cannabinoid Receptor Modulators
App 20180280386 - Thatte; Jayant ; et al. | 2018-10-04 |
Crystalline L-arginine Salt Of (r)-2-(7-(4-cyclopentyl-3- (trifluoromethyl)benzyloxy)-1,2,3, 4-tetrahydrocyclo-penta [b]indol-3-yl)acetic Acid(compound1) For Use In Sipi Receptor-associated Disorders
App 20180186738 - Blackburn; Anthony C. ; et al. | 2018-07-05 |
Cannabinoid receptor modulators
Grant 9,867,822 - Thatte , et al. January 16, 2 | 2018-01-16 |
Cannabinoid Receptor Modulators
App 20170304327 - Thatte; Jayant ; et al. | 2017-10-26 |
Modified-release Dosage Forms Of 5-ht2c Agonists Useful For Weight Management
App 20170246179 - Shao; Zezhi Jesse ; et al. | 2017-08-31 |
Cannabinoid Receptor Modulators
App 20170143704 - Thatte; Jayant ; et al. | 2017-05-25 |
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators
App 20170144993 - Blackburn; Anthony C. ; et al. | 2017-05-25 |
Cannabinoid receptor modulators
Grant 9,597,340 - Thatte , et al. March 21, 2 | 2017-03-21 |
Cannabinoid receptor modulators
Grant 9,492,447 - Thatte , et al. November 15, 2 | 2016-11-15 |
Crystalline forms and processes for the preparation of cannabinoid receptor modulators
Grant 9,458,136 - Blackburn , et al. October 4, 2 | 2016-10-04 |
Cannabinoid Receptor Modulators
App 20160271127 - Thatte; Jayant ; et al. | 2016-09-22 |
Salts Of Lorcaserin With Optically Active Acids
App 20160151381 - Blackburn; Anthony C. ; et al. | 2016-06-02 |
Salts of lorcaserin with optically active acids
Grant 9,248,133 - Blackburn , et al. February 2, 2 | 2016-02-02 |
Cannabinoid Receptor Modulators
App 20150126477 - Thatte; Jayant ; et al. | 2015-05-07 |
Cannabinoid Receptor Modulators
App 20140206649 - Thatte; Jayant ; et al. | 2014-07-24 |
Crystalline Forms And Processes For The Preparation Of Cannabinoid Receptor Modulators
App 20140135345 - Blackburn; Anthony C. ; et al. | 2014-05-15 |
Modified-release Dosage Forms Of 5-ht2c Agonists Useful For Weight Management
App 20130315994 - Shao; Zezhi Jesse ; et al. | 2013-11-28 |
Salts Of Lorcaserin With Optically Active Acids
App 20130310369 - Blackburn; Anthony C. ; et al. | 2013-11-21 |
| 